DOCELIEVA 120 MG is an Injection medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | DOCELIEVA 120 MG |
|---|---|
| Composition | Docetaxel Injection IP 120 MG |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Injection |
| Packaging | Vial |
| Country of Origin | India |
DOCELIEVA 120 MG (Docetaxel Injection IP 120 MG) is a widely used Injection medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
DOCELIEVA 120 MG (Docetaxel Injection IP 120 mg) is a prescription anticancer medicine containing Docetaxel 120 mg, a chemotherapy agent belonging to the Taxane class of anticancer drugs. Docetaxel is widely used in the treatment of various cancers by interfering with cancer cell division and preventing tumor growth.
Docetaxel works by stabilizing microtubules within cancer cells, preventing their normal breakdown during cell division. This disruption inhibits cancer cell replication and ultimately leads to cancer cell death. Due to its proven efficacy, Docetaxel is an important component of modern oncology treatment protocols.
DOCELIEVA 120 MG is commonly prescribed for the treatment of breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric cancer, and head and neck cancers. It may be administered as a single-agent therapy or in combination with other anticancer medicines depending on the treatment plan.
The medicine is administered intravenously under the supervision of qualified healthcare professionals experienced in cancer treatment.
DOCELIEVA 120 MG is commonly used for:
Manufactured according to stringent pharmaceutical quality standards, DOCELIEVA 120 MG is designed to provide consistent quality, safety, and therapeutic effectiveness.
Patients receiving Docetaxel therapy require regular monitoring of blood counts, liver function, and overall health status throughout treatment.
Due to its broad clinical applications and proven effectiveness, DOCELIEVA 120 MG remains a key medicine in modern cancer management.
DOCELIEVA 120 MG (Docetaxel Injection IP 120 mg) is primarily used in the treatment and management of various cancers.
Docetaxel is widely used in early-stage, locally advanced, and metastatic breast cancer treatment.
The medicine is commonly prescribed as part of lung cancer chemotherapy regimens.
Docetaxel is frequently used in metastatic castration-resistant prostate cancer treatment.
The medicine may be incorporated into treatment plans for advanced stomach cancer.
Doctors may prescribe Docetaxel as part of combination chemotherapy protocols.
The medicine is utilized in various oncology treatment programs depending on clinical requirements.
Docetaxel is often used alongside other anticancer medicines to improve treatment outcomes.
Docetaxel belongs to a class of medicines known as Taxane Anticancer Agents.
DOCELIEVA works by:
This mechanism helps control cancer development and supports effective disease management.
Like all medicines, DOCELIEVA 120 MG may cause side effects in some patients. The severity and frequency of side effects vary among individuals.
Reduction in white blood cells, red blood cells, and platelets may occur.
Weakness and tiredness are commonly reported.
Temporary hair loss may occur during treatment.
Digestive discomfort may develop during therapy.
Numbness, tingling, or nerve-related symptoms may occur.
Some patients may experience swelling in the hands, feet, or legs.
Inflammation or ulcers inside the mouth may occur.
Digestive disturbances may develop during treatment.
Changes in nail color or texture may be observed.
Seek immediate medical attention if you experience:
Patients should contact their healthcare provider immediately if serious symptoms occur.
The dosage of DOCELIEVA 120 MG (Docetaxel Injection IP 120 mg) should always be determined by a qualified oncologist.
Treatment recommendations vary according to the disease being treated.
Dosage is generally calculated according to body surface area.
Hepatic function plays an important role in dosage planning.
Laboratory monitoring helps guide treatment decisions.
Concurrent anticancer medicines may influence dosage schedules.
Before starting treatment, inform your doctor if you have:
Patients receiving Docetaxel therapy may require:
Patients should also disclose all prescription medicines, supplements, vitamins, and herbal products they are taking to avoid potential drug interactions.
Pregnant and breastfeeding women should not use this medicine unless specifically advised by a healthcare professional.
It is used for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, head and neck cancer, and other advanced solid tumors.
Docetaxel is a taxane-based chemotherapy medicine that prevents cancer cells from dividing and multiplying.
Yes. Docetaxel is a widely used chemotherapy agent in oncology.
Yes. Temporary hair loss is a common side effect during treatment.
Yes. Peripheral neuropathy, including numbness and tingling in the hands and feet, may occur.
Yes. The medicine may lower white blood cells, red blood cells, and platelet counts.
Yes. Regular blood tests and medical evaluations are important throughout therapy.
Yes. This medicine should only be administered by qualified healthcare professionals experienced in oncology treatment.